Market Trends Sage sues Biogen in wake of $469M buyout offer: report (BIIB:NASDAQ)By admin8996erT0allJanuary 17, 2025 Veronique DSage Therapeutics (NASDAQ:SAGE) is reportedly suing Biogen (NASDAQ:BIIB) over enforcement of a standstill agreement in the wake of an…
